|
RSRC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.091050E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.428000E-02 |
| Normal-vs-Stage2 |
4.540600E-01 |
| Normal-vs-Stage3 |
4.215800E-01 |
| Normal-vs-Stage4 |
4.050200E-02 |
| Stage1-vs-Stage2 |
5.075000E-01 |
| Stage1-vs-Stage3 |
4.270000E-01 |
| Stage1-vs-Stage4 |
7.193200E-01 |
| Stage2-vs-Stage3 |
9.793600E-01 |
| Stage2-vs-Stage4 |
3.986800E-01 |
| Stage3-vs-Stage4 |
3.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.343640E-01 |
| Normal-vs-AfricanAmerican |
1.126210E-01 |
| Normal-vs-Asian |
2.307600E-01 |
| Caucasian-vs-AfricanAmerican |
6.215800E-01 |
| Caucasian-vs-Asian |
7.535200E-01 |
| AfricanAmerican-vs-Asian |
8.860000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.364300E-03 |
| Normal-vs-Female |
1.857820E-01 |
| Male-vs-Female |
8.27190000000089E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.519220E-01 |
| Normal-vs-Extreme_Weight |
5.017000E-03 |
| Normal-vs-Obese |
4.590800E-01 |
| Normal-vs-Extreme_Obese |
7.266600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.809800E-01 |
| Normal_Weight-vs-Obese |
4.002000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.368800E-01 |
| Extreme_Weight-vs-Obese |
6.106100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.214000E-01 |
| Obese-vs-Extreme_Obese |
9.166400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.694200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.090800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.260300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.297600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.026400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.497600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.320000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.360200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.416400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.460200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.167900E-02 |
| Normal-VS-Type2 PRCC |
1.713200E-01 |
| Normal-VS-KIRP CIMP |
2.213600E-01 |
| Normal-VS-Unclassified PRCC |
3.779200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.689200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.448620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.630000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.389990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.620000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.977590E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.695900E-03 |
| Normal-vs-N1 |
3.996800E-01 |
| Normal-vs-N2 |
2.162600E-01 |
| N0-vs-N1 |
5.404400E-03 |
| N0-vs-N2 |
8.666800E-01 |
| N1-vs-N2 |
3.228600E-01 |
|
|
